Found: 77
Select item for more details and to access through your institution.
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00498-6
- By:
- Publication type:
- Article
Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1412, doi. 10.3390/cells10061412
- By:
- Publication type:
- Article
Ginseng Protects Against Respiratory Syncytial Virus by Modulating Multiple Immune Cells and Inhibiting Viral Replication.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Immunomodulatory Activity of Red Ginseng against Influenza A Virus Infection.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0205071
- By:
- Publication type:
- Article
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190868
- By:
- Publication type:
- Article
Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination.
- Published in:
- FASEB Journal, 2022, v. 36, n. 3, p. 1, doi. 10.1096/fj.202101703R
- By:
- Publication type:
- Article
Built‐in RNA‐mediated chaperone (chaperna) for antigen folding tailored to immunized hosts.
- Published in:
- Biotechnology & Bioengineering, 2020, v. 117, n. 7, p. 1990, doi. 10.1002/bit.27355
- By:
- Publication type:
- Article
Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.
- Published in:
- Biotechnology & Bioengineering, 2015, v. 112, n. 6, p. 1102, doi. 10.1002/bit.25537
- By:
- Publication type:
- Article
Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.
- Published in:
- Archives of Virology, 2013, v. 158, n. 6, p. 1275, doi. 10.1007/s00705-013-1612-z
- By:
- Publication type:
- Article
Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 7, p. 1364, doi. 10.1038/mt.2014.33
- By:
- Publication type:
- Article
Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 2, p. 485, doi. 10.1038/mt.2012.246
- By:
- Publication type:
- Article
Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 362, doi. 10.3390/vaccines12040362
- By:
- Publication type:
- Article
Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1209, doi. 10.3390/vaccines11071209
- By:
- Publication type:
- Article
Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 866, doi. 10.3390/vaccines11040866
- By:
- Publication type:
- Article
Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1383, doi. 10.3390/vaccines10091383
- By:
- Publication type:
- Article
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060944
- By:
- Publication type:
- Article
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040584
- By:
- Publication type:
- Article
Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1324, doi. 10.3390/vaccines9111324
- By:
- Publication type:
- Article
Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1061, doi. 10.3390/vaccines9101061
- By:
- Publication type:
- Article
An Update on mRNA-Based Viral Vaccines.
- Published in:
- Vaccines, 2021, v. 9, n. 9, p. 965, doi. 10.3390/vaccines9090965
- By:
- Publication type:
- Article
Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 316, doi. 10.3390/vaccines9040316
- By:
- Publication type:
- Article
Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 232, doi. 10.3390/vaccines9030232
- By:
- Publication type:
- Article
Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 716, doi. 10.3390/vaccines8040716
- By:
- Publication type:
- Article
Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 648, doi. 10.3390/vaccines8040648
- By:
- Publication type:
- Article
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus.
- Published in:
- Vaccines, 2018, v. 6, n. 4, p. 66, doi. 10.3390/vaccines6040066
- By:
- Publication type:
- Article
Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.
- Published in:
- Vaccines, 2017, v. 5, n. 4, p. 52, doi. 10.3390/vaccines5040052
- By:
- Publication type:
- Article
New vaccines against influenza virus.
- Published in:
- Clinical & Experimental Vaccine Research, 2014, v. 3, n. 1, p. 12, doi. 10.7774/cevr.2014.3.1.12
- By:
- Publication type:
- Article
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02725-4
- By:
- Publication type:
- Article
Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10612, doi. 10.3390/ijms241310612
- By:
- Publication type:
- Article
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice.
- Published in:
- Immunity & Ageing, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12979-023-00344-w
- By:
- Publication type:
- Article
Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice.
- Published in:
- Advanced Healthcare Materials, 2020, v. 9, n. 2, p. N.PAG, doi. 10.1002/adhm.201901176
- By:
- Publication type:
- Article
DNA Vaccination in the Skin Using Microneedles Improves Protection Against Influenza.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 7, p. 1472, doi. 10.1038/mt.2012.69
- By:
- Publication type:
- Article
Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage.
- Published in:
- Pharmaceutical Research, 2011, v. 28, n. 1, p. 135, doi. 10.1007/s11095-010-0134-6
- By:
- Publication type:
- Article
Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56169-5
- By:
- Publication type:
- Article
<i>Lactobacillus plantarum</i> DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075368
- By:
- Publication type:
- Article
A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066316
- By:
- Publication type:
- Article
Protective Effect of Ginseng Polysaccharides on Influenza Viral Infection.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033678
- By:
- Publication type:
- Article
Increased Inflammatory Signaling and Lethality of Influenza H1N1 by Nuclear Thioredoxin-1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018918
- By:
- Publication type:
- Article
Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0014538
- By:
- Publication type:
- Article
Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0013972
- By:
- Publication type:
- Article
Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012410
- By:
- Publication type:
- Article
Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009161
- By:
- Publication type:
- Article
Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0007152
- By:
- Publication type:
- Article
Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004667
- By:
- Publication type:
- Article
Antiviral activity of ginseng extract against respiratory syncytial virus infection.
- Published in:
- International Journal of Molecular Medicine, 2014, v. 34, n. 1, p. 183, doi. 10.3892/ijmm.2014.1750
- By:
- Publication type:
- Article
Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 8, p. 1, doi. 10.1371/journal.ppat.1010755
- By:
- Publication type:
- Article
Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.
- Published in:
- International Journal of Nanomedicine, 2015, v. 10, p. 4491, doi. 10.2147/IJN.S83493
- By:
- Publication type:
- Article
Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83704-0
- By:
- Publication type:
- Article
TBK1 regulates regeneration of pancreatic β-cells.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-76600-6
- By:
- Publication type:
- Article